Effect of ipratropium bromide on serum IL-13, TGF-β1 and VEGF in children with asthma / 中国生化药物杂志

ABSTRACT

Objective To explore the effect of ipratropium bromide on serum interleukin-13 (IL-13), transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) in children with asthma.Methods Eighty-six children with asthma in pediatrics department of Hanggang Hospital from January 2014 to June 2014 were selected and divided into two groups according to different therapy, 43 cases in each group.Control group received aminophylline of intravenous drip infusion and salbutamol and ketotifen orally.Experimental group received ipratropium bromide of aerosol inhalation on the basis of control group, twice daily and treated for two courses, 7 days of one course.The clinical efficacy , serum IL-13, TGF-β1, VEGF and lung function post-treatment were compared between two groups.Results The total curative effect of experimental group was 90.69%, which was significantly higher than 72.09% of control group(χ2 =4.91,P<0.05).The serum levels of IL-13, TGF-β1 and VEGF after 3, 7 and 14 days’ treatment in two groups were lower than those pre-treatment(P<0.05).The above indicators of experimental group were lower than those of control group at the same time point(P<0.05).The FEV1 and FEV1/FVC% after 7, 14 days’ treatment in control group and the above indicators after 3, 7, 14 days’ treatment in experimental group were significantly higher than those pre-treatment (P<0.05).The above indicators of experimental group were higher than those of control group at the same time point (P<0.05).Conclusion Ipratropium bromide could affect serum IL-13, TGF-β1 and VEGF levels in children with asthma, improve lung function and clinical curative effect.